Dr. Grossman stressed that the quality of programs and services provided at Winthrop and its affiliated practices was a key determining factor for NYU Langone, adding, "It was important for us to work with an organization that shares our level of commitment to patient care. From the continuity and quality-of-care perspective alone, we have an excellent foundation for establishing a meaningful relationship."

According to John Collins, Winthrop's President and CEO, "We have been successful in completing this agreement with NYU Langone because both parties share a mutual respect and a mutual commitment to delivering the highest quality healthcare to the residents of the New York region. I think NYU Langone recognizes that Winthrop stands as a truly unique healthcare institution on Long Island – a major academic and research hospital that delivers high quality care in an extremely personal and compassionate environment. And we recognize in NYU Langone a partner who shares our commitment to excellence, who places the utmost value on the contributions of our clinical staff, and who will be able to help us continue to expand our services to meet the needs of our community as well as provide access to a whole new source of world-class medical care."


Following are some of the key components of the affiliation agreement:

Provide an initial capital investment and develop a long term master plan which will serve as a framework for future changes and expansion of the campus for both inpatient and ambulatory activities based upon projected needs.

Implementation and integration of the Epic electronic medical records system will be focused on Winthrop's ambulatory practices to develop a system-wide, state-of-the art IT infrastructure and connectivity to support clinical integration and population health management initiatives and analytics. Winthrop recently converted to the Cerner Soarian Electronic Medical Record system for all inpatient care, which will stay in place for the foreseeable future.

Structurally, Winthrop's operations will remain under the direction of the current Board of Directors and Administration. John Collins will continue as Winthrop's President and CEO, and will report directly to Dr. Grossman and to the Winthrop Board of Directors. Initially, one member of Winthrop's Board of Directors will also take a seat on the NYU Langone Board, and several members of NYU Langone's Board will become members of Winthrop's Board. Additionally, Winthrop's medical teaching faculty will retain their faculty appointments within Stony Brook University's School of Medicine, and undergraduate medical education, in which 80 third- and fourth-year Stony Brook medical students are trained on the Winthrop campus, will also remain in effect. Following the initial five years of the affiliation, Winthrop will complete a full asset merger with NYU Langone's hospitals.

Mergers and Acquisitions Homepage